Fluticasone Furoate/Levocabastine

糠酸氟替卡松/左卡巴斯汀

Report date: 2025/11/14 13:58:44

Base Information

Drug NameFluticasone Furoate/Levocabastine
Drug Alias NameFF/levocabastine左卡巴斯汀+糠酸氟替卡松Levocabastine/FF糠酸氟替卡松/盐酸左卡巴斯汀Fluticasone Furoate+Levocabastine +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsHistamine H1 receptor antagonists
TargetsHistamine H1 receptorGlucocorticoid receptor
Therapy Area/IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsYes Fluticasone FuroateLevocabastine Hydrochloride
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Other Information

ATC CodeN/A
Related LinksN/A